Aline Aparecida Macedo Marques

Aline Aparecida Macedo Marques

Auto-generated profile, based on publicly available information

Aline Aparecida Macedo Marques

Laboratório de Farmacologia Cardiovascular, Faculdade de Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
ASAniely Oliveira Silva
Aniely Oliveira Silva
BLBethania Lorencone
Bethania Lorencone
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Therapeutic approaches for the treatment of dyslipidemia and atherosclerosis have radically changed in recent decades. Part of this advance undeniably stems from basic biomedical research that has provided a better understanding and identification of new therapeutic targets. The aim of this work was to develop a model to induce atherogenesis and hepato-renal impairment in female Wistar rats. The following groups received the respective treatments for 60 days: control animals, non-ovariectomized rats that received an atherogenic diet (NEAD), ovariectomized rats that received an atherogenic diet (NOAD), non-ovariectomized rats that received an atherogenic diet and oral Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME; LEAD), and ovariectomized rats that received an atherogenic diet and oral l-NAME (LOAD). Animals in the NEAD, NOAD, LEAD, and LOAD groups also received methimazole and cholecalciferol daily. Urinary, biochemical, hemodynamic, and electrocardiographic parameters and renal function were assessed. Samples of the liver, heart, kidney, and arteries were collected to investigate redox status and perform histopathological analyses. All of the groups developed dyslipidemia and hepatic steatosis. Only the NEAD group developed arterial lesions that were compatible with fatty streaks. Renal function was significantly impaired in the LEAD and NOAD groups. These results indicate a viable alternative to induce atherogenesis and hepato-renal impairment in female rats.

12 July 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KMKaryne Moreno
Karyne Moreno
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
GSGabriela Pereira da Silva
Gabriela Pereira da Silva
BLBethania Lorencone
Bethania Lorencone
CFClara Soligo Fortini
Clara Soligo Fortini
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Cardiovascular disease (CVD) is the leading cause of death among non-communicable diseases. There is a lack of valid animal models that mimic associations among multiple cardiovascular risk factors in humans. The present study developed an animal model that uses multiple cardiovascular risk factors—namely, hypertension, hypothyroidism, and a high-fat diet (HFD). Two models of hypertension were used: renovascular hypertension (two-kidney, one clip [2K1C]) and spontaneously hypertensive rats (SHRs). The naive group was composed of normotensive rats. Twelve weeks after surgery to induce renovascular hypertension, rats in the 2K1C and SHR groups underwent thyroidectomy. The HFD was then implemented for 6 weeks. Renal function, serum redox status, biochemical CVD markers, electrocardiographic profile, blood pressure, mesenteric vascular bed reactivity, histopathology, and morphometry were investigated. Both experimental models induced dyslipidemia, renal function impairment, and hepatic steatosis, accompanied by higher levels of different inflammatory markers and serum oxidative stress. These alterations contributed to end-organ damage in all hypertensive rats. Our findings corroborate a viable alternative model that involves multiple cardiovascular risk factors and resembles conditions that are seen in humans. Both models mimicked CVD, but our data show that SHRs exhibit more significant pathophysiological changes.

1 June 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
BLBethania Lorencone
Bethania Lorencone
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior

15 November 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
PZPriscila Megda João Job Zago
Priscila Megda João Job Zago
GSGustavo Ratti Da Silva
Gustavo Ratti Da Silva
EAEduarda Carolina Amaral
Eduarda Carolina Amaral
LBLorena Neris Barboza
Lorena Neris Barboza
FBFernanda de Abreu Braga
Fernanda de Abreu Braga
Francislaine Aparecida dos Reis LíveroFrancislaine Aparecida dos Reis Lívero
Francislaine Aparecida dos Reis Lívero
Croton urucurana Baill. is a native Brazilian tree, popularly known as sangra-dágua or sangue-de-dragão, based on the red resinous sap of the trunk. Its use has been transmitted through generations based on popular tradition that attributes analgesic, anti-inflammatory, and cardioprotective properties to the tree. However, its cardioprotective effects have not yet been scientifically investigated. Thus, the present study investigated the pharmacological response to an ethanol-soluble fraction from the leaves of C. urucurana in Wistar rats exposed to smoking and dyslipidemia, two important cardiovascular risk factors. The extract was evaluated by high-performance liquid chromatography. Wistar rats received a 0.5 cholesterol-enriched diet and were exposed to cigarette smoke (9 cigarettes/day for 10weeks). During the last 5weeks, the animals were orally treated with vehicle (negative control group), C. urucurana extract (30, 100, and 300mg/kg), or simvastatin (2.5mg/kg)+enalapril (15mg/kg). One group of rats that was not exposed to these risk factors was also evaluated (basal group). Electrocardiograms and systolic, diastolic, and mean blood pressure were measured. Blood was collected to measure total cholesterol, triglycerides, urea, and creatinine. The heart and kidneys were collected and processed for oxidative status and histopathological evaluation. The phytochemical analysis revealed different classes of flavonoids and condensed tannins. The model induced dyslipidemia and cardiac and renal oxidative stress and increased levels of urea and creatinine in the negative control group. Treatment with the C. urucurana extract (300mg/kg) and simvastatin+enalapril decreased cholesterol and triglyceride levels. In contrast to simvastatin+enalapril treatment, the C. urucurana extract exerted cardiac and renal antioxidant effects. No alterations of electrocardiograms, blood pressure, or histopathology were observed between groups. These findings indicate that C. urucurana exerts lipid-lowering, renal, and cardioprotective effects against oxidative stress in a preclinical model of multiple risk factors for heart disease.

20 November 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LMLuciane M. Monteiro
Luciane M. Monteiro
LKLislaine Maria Klider
Lislaine Maria Klider
AMAline A. M. Marques
Aline A. M. Marques
PFPaulo Vitor Farago
Paulo Vitor Farago
JEJanaína Emiliano
Janaína Emiliano
JMJane Manfron
Jane Manfron
Piper amalago L. is used in Brazilian traditional medicine to treat inflammation, chest pain, and anxiety. This study aimed to investigate the safety and the renal and cardiovascular effects of the volatile oil (VO) and the aqueous (AE) and hydroalcoholic (HE) extracts from P. amalago. The gas chromatography-mass spectrometry analyses identified 47 compounds in the VO, with β-cyclogermacrene, spathulenol, β-phellandrene, and α-pinene standing out. Among the 47 compounds also found in AE and HE by liquid chromatography-mass spectrometry, glycosylated flavones, organic acids, amino acids, and amides were highlighted. Some examples of these compounds are methoxy-methylenedioxy cis-cinnamoyl pyrrolidine, methoxy-methylenedioxy trans-cinnamoyl pyrrolidine, and cyclobutene-2,4-bis-(1,3-benzodioxol-5-methoxy-6-yl)-1,3-dicarboxapyrrolidide. The acute toxicity experiments were conducted on female rats (n = 5). The cardiorenal assays (n = 8) and evaluations of vasodilatory effects on the mesenteric vascular bed (n = 5) were conducted on male rats. In either extract or VO, there were no mortality or changes in relative weights or histopathological analysis of the organs. Urinary volume and renal electrolyte excretion were elevated significantly during repeated dose 7-day treatment with different preparations from P. amalago. None of the preparations induced hypotension or changes in cardiac electrical activity. Only HE promoted significant vasodilatory effects in rats’ isolated mesenteric vascular beds. These effects were completely abolished in the presence of L-NAME plus 4-aminopyridine. Therefore, P. amalago leaves are safe and present diuretic activity after acute and repeated dose administration over 7 days. Moreover, the HE induced significant vasodilator response in rats’ mesenteric vascular beds by NO/cGMP pathway and voltage-dependent K+ channels activation.

16 December 2025 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
LKLislaine Maria Klider
Lislaine Maria Klider
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
KMKaryne Moreno
Karyne Moreno
GSGabriela Pereira da Silva
Gabriela Pereira da Silva
KSKelly Cristina Barboza dos Santos
Kelly Cristina Barboza dos Santos
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior